An AI model created by researchers at King’s can detect signs of faulty repair mechanisms in ovarian cancer cells, potentially leading to a low-cost, widely accessible diagnostic tool in the future.
Reducing damage to the nuclei of heart muscle cells improved heart function and extended survival in mice with a form of inherited heart disease, according to a new study led by Cornell researchers.
Abbott (NYSE: ABT) has received approval in Europe for its updated Cologuard Plus screening test for colorectal cancer, ahead of plans for a phased rollout across the continent.
Quercetin is found in citrus fruits, onions and buckwheat and is known for its anti-inflammatory properties. Now researchers at Universitätsklinikum Erlangen at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) have investigated how the plant compound could help treat lung cancer.
Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy. A study has now demonstrated that a blood test (liquid biopsy) can reliably detect lingering lung cancer traces even in the earliest clinical stages, long before a tumor is large enough to show up on a scan.
In the event of a heart attack, the affected part of the heart muscle can no longer be supplied with oxygen and nutrients. As a result, the heart muscle cells (cardiomyocytes) die off. Scar tissue forms, and heart function is impaired. This often leads to chronic heart failure—also known in medical terms as cardiac insufficiency. It is one of the most common causes of death in the Western world.
As a pathologist, Dr. Christopher Owens has spent his career trying to improve his methods of catching precancerous colorectal polyps in patients. If he could catch cases earlier, fewer people would develop colorectal cancer, he said.
Researchers are investigating whether the body’s built-in response to low oxygen can be harnessed to reduce heart damage during heart attacks and surgery, using drugs that are already available.
For older adults with heart failure (HF), leaving the hospital alive does not always mean returning to an independent life. Loss of independence can reduce quality of life, increase caregiver burden and raise care needs. Yet most prognostic approaches focus on death or rehospitalization, making it difficult to identify patients likely to survive while losing independence.
Imagine stepping into a virtual world while sensors embedded in wearable technology track the way that you move outside in the real world. For an individual with Parkinson’s disease, this opportunity gives researchers a detailed look into how the disease affects movement and offers insight into how it can be more effectively treated.